Incorporating Placebo Response in Quantitative Systems Pharmacology Models

Incorporating Placebo Response in Quantitative Systems Pharmacology Models

Bibliographic Details
Main Authors:	Evan B. Wang, Lei Shen, Michael Heathman, Jason R. Chan
Format:	Article
Language:	English
Published:	Wiley 2019-06-01
Series:	CPT: Pharmacometrics & Systems Pharmacology
Online Access:	https://doi.org/10.1002/psp4.12412

Similar Items

A Flexible Approach for Context‐Dependent Assessment of Quantitative Systems Pharmacology Models
by: Saroja Ramanujan, et al.
Published: (2019-06-01)

Quantitative Systems Pharmacology Model of a Masked, Tumor‐Activated Antibody
by: Mark Stroh, et al.
Published: (2019-09-01)

A quantitative systems pharmacology approach, incorporating a novel liver model, for predicting pharmacokinetic drug-drug interactions.
by: Mohammed H Cherkaoui-Rbati, et al.
Published: (2017-01-01)

The promises of quantitative systems pharmacology modelling for drug development
by: V.R. Knight-Schrijver, et al.
Published: (2016-01-01)

Industrialization of Quantitative Systems Pharmacology
by: Brian Topp, et al.
Published: (2019-06-01)

Best Practices to Maximize the Use and Reuse of Quantitative and Systems Pharmacology Models: Recommendations From the United Kingdom Quantitative and Systems Pharmacology Network
by: Lourdes Cucurull‐Sanchez, et al.
Published: (2019-05-01)

Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis.
by: André Russowsky Brunoni, et al.
Published: (2009-01-01)

Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities
by: Erica L. Bradshaw, et al.
Published: (2019-11-01)

The Emerging Discipline of Quantitative Systems Pharmacology
by: Tarek A Leil, et al.
Published: (2015-06-01)

Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies
by: Edington, Collin D, et al.
Published: (2018)

The placebo response rate and nocebo events in obesity pharmacological trials. A systematic review and meta-analysis
by: Yip Han Chin, et al.
Published: (2022-12-01)

Quantitative systems pharmacology modeling provides insight into inter‐mouse variability of Anti‐CTLA4 response
by: Wenlian Qiao, et al.
Published: (2022-07-01)

Quantitative systems pharmacology in the age of artificial intelligence
by: Benjamin Ribba
Published: (2023-12-01)

Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma
by: R. E. Abrams, et al.
Published: (2022-06-01)

A quantitative systems pharmacology model of the pathophysiology and treatment of COVID-19 predicts optimal timing of pharmacological interventions
by: Rohit Rao, et al.
Published: (2023-04-01)

Considerations for Adapting Pre-existing Mechanistic Quantitative Systems Pharmacology Models for New Research Contexts
by: Michael Weis, et al.
Published: (2019-04-01)

Conceptual and organizational barriers to quantitative systems pharmacology modeling of pathophysiological systemic drug hypotheses
by: Ronald Gieschke, et al.
Published: (2022-12-01)

Quantitative Systems Pharmacology: A Regulatory Perspective on Translation
by: Issam Zineh
Published: (2019-06-01)

Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies
by: Peter Bloomingdale, et al.
Published: (2021-05-01)

Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment
by: Yan Ji, et al.
Published: (2023-03-01)

The Myth of the Placebo Response
by: Wayne B. Jonas
Published: (2019-08-01)

Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model.
by: Alvaro Ruiz-Martinez, et al.
Published: (2022-07-01)

Deriving mechanism‐based pharmacodynamic models by reducing quantitative systems pharmacology models: An application to warfarin
by: Undine Falkenhagen, et al.
Published: (2023-04-01)

A Review of Quantitative Systems Pharmacology Models of the Coagulation Cascade: Opportunities for Improved Usability
by: Douglas Chung, et al.
Published: (2023-03-01)

A quantitative systems pharmacology model for certolizumab pegol treatment in moderate-to-severe psoriasis
by: Pablo Coto-Segura, et al.
Published: (2023-09-01)

Quantitative systems pharmacology model for Alzheimer’s disease to predict the effect of aducanumab on brain amyloid
by: Lin Lin, et al.
Published: (2022-03-01)

Quantitative Systems Pharmacology and Physiologically‐Based Pharmacokinetic Modeling With mrgsolve: A Hands‐On Tutorial
by: Ahmed Elmokadem, et al.
Published: (2019-12-01)

Potential Issues With Virtual Populations When Applied to Nonlinear Quantitative Systems Pharmacology Models
by: Stephen Duffull, et al.
Published: (2020-11-01)

Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemia[S]
by: Victor Sokolov, et al.
Published: (2019-09-01)

Placebo and nocebo effects and mechanisms associated with pharmacological interventions: an umbrella review
by: Fabrizio Benedetti, et al.
Published: (2023-10-01)

Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging
by: Wanigasekera, V, et al.
Published: (2017)

Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging
by: Wanigasekera, V, et al.
Published: (2018)

Quantitative systems pharmacology of the eye: Tools and data for ocular QSP
by: Lars Kuepfer, et al.
Published: (2023-03-01)

Quantitative Measurements of Pharmacological and Toxicological Activity of Molecules
by: Renata R. Kazakova, et al.
Published: (2022-11-01)

Quantitative Systems Pharmacology Modeling of Acid Sphingomyelinase Deficiency and the Enzyme Replacement Therapy Olipudase Alfa Is an Innovative Tool for Linking Pathophysiology and Pharmacology
by: Chanchala D. Kaddi, et al.
Published: (2018-07-01)

Eliciting the antitumor immune response with a conditionally activated PD‐L1 targeting antibody analyzed with a quantitative systems pharmacology model
by: Alberto Ippolito, et al.
Published: (2024-01-01)

A Dynamic Quantitative Systems Pharmacology Model of Inflammatory Bowel Disease: Part 1 – Model Framework
by: Katharine V. Rogers, et al.
Published: (2021-01-01)

Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer
by: Leisha A Emens, et al.
Published: (2021-02-01)

QSP‐IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno‐Oncology Applications
by: Richard J. Sové, et al.
Published: (2020-09-01)

Quantitative systems pharmacology model of the amyloid pathway in Alzheimer's disease: Insights into the therapeutic mechanisms of clinical candidates
by: Vidya Ramakrishnan, et al.
Published: (2023-01-01)